Terms: = Prostate cancer AND TG, Thyroglobulin
313 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays.
Galior KD; Ladwig PM; Snyder MR; Algeciras-Schimnich A; Bornhorst JA; Block DR; Baumann NA; Willrich MAV
Clin Biochem; 2023 Nov; 121-122():110685. PubMed ID: 37972806
[TBL] [Abstract] [Full Text] [Related]
3. Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients.
Cattrini C; Manfredi M; Barboro P; Ghirimoldi M; Mennitto A; Martini V; Battioni A; Le Van M; Gobbato S; Branni C; Ayed RB; Pinato DJ; Catalano F; Zanardi E; Boccardo F; Gennari A
Sci Rep; 2023 Oct; 13(1):17791. PubMed ID: 37853018
[TBL] [Abstract] [Full Text] [Related]
4. Open RT Structures: A Solution for TG-263 Accessibility.
Anderson BM; Padilla L; Ryckman JM; Covington E; Hong DS; Woods K; Katz MS; Zuhour R; Estes C; Moore KL; Bojechko C
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):859-863. PubMed ID: 37778423
[TBL] [Abstract] [Full Text] [Related]
5. Association between genetically proxied HMGCR inhibition and male reproductive health: A Mendelian randomization study.
Yan Z; Xu Y; Li K; Liu L
Medicine (Baltimore); 2023 Sep; 102(39):e34690. PubMed ID: 37773823
[TBL] [Abstract] [Full Text] [Related]
6. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer.
Feng F; Zhong YX; Chen Y; Lin FX; Huang JH; Mai Y; Zhao PP; Wei W; Zhu HC; Xu ZP
BMC Urol; 2023 Jul; 23(1):120. PubMed ID: 37452418
[TBL] [Abstract] [Full Text] [Related]
8. Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines.
Atobatele AG; Tonoli E; Vadakekolathu J; Savoca MP; Barr M; Kataria Y; Rossanese M; Burhan I; McArdle S; Caccamo D; Verderio EAM
Cell Death Dis; 2023 May; 14(5):317. PubMed ID: 37160910
[TBL] [Abstract] [Full Text] [Related]
9. cancer in Ecuadorian subjects with Laron syndrome (ELS).
Guevara-Aguirre J; Peña G; Pazmiño G; Acosta W; Saavedra J; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36971780
[TBL] [Abstract] [Full Text] [Related]
10. A pair of deep learning auto-contouring models for prostate cancer patients injected with a radio-transparent versus radiopaque hydrogel spacer.
Wang Y; Boyd G; Zieminski S; Kamran SC; Zietman AL; Miyamoto DT; Kirk MC; Efstathiou JA
Med Phys; 2023 Jun; 50(6):3324-3337. PubMed ID: 36940384
[TBL] [Abstract] [Full Text] [Related]
11. Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis.
Lv D; Cen S; Yang S; Zou Z; Zhong J; Pan Z; Deng N; Li Y; Wu K; Wang J; Liu P
Cell Cycle; 2023 May; 22(9):1101-1115. PubMed ID: 36740902
[TBL] [Abstract] [Full Text] [Related]
12. The first peptide derivatives of dioxybiphenyl-bridged spiro cyclotriphosphazenes: In vitro cytotoxicity activities and DNA damage studies.
Koran K; Çalışkan E; Altay Öztürk D; Çapan İ; Tekin S; Sandal S; Orhan Görgülü A
Bioorg Chem; 2023 Mar; 132():106338. PubMed ID: 36603512
[TBL] [Abstract] [Full Text] [Related]
13. The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial.
Karkeet RM; Zekri AN; Sayed-Ahmed MM; Sherif GM; Salem SE; Abdelbary A; Fouad MA; Saad SY
PLoS One; 2022; 17(12):e0278282. PubMed ID: 36480560
[TBL] [Abstract] [Full Text] [Related]
14. Pediatric reference interval verification for 17 specialized immunoassays and cancer markers on the Abbott Alinity i system in the CALIPER cohort of healthy children and adolescents.
Bohn MK; Wilson S; Schneider R; Massamiri Y; Randell EW; Adeli K
Clin Chem Lab Med; 2023 Jan; 61(1):123-132. PubMed ID: 36117243
[TBL] [Abstract] [Full Text] [Related]
15. Association Between Vitamin D Binding Protein Gene Polymorphism (rs7041), Vitamin D Receptor, and 25-Hydroxyvitamin D Serum Levels With prostate cancer in Kurdish Population in West of Iran.
Amiri M; Elieh Ali Komi D; Vaisi-Raygani A; Kiani A; Moradi M; Aliyari M; Rahimi Z; Mohammadi-Noori E; Bashiri H
Pathol Oncol Res; 2022; 28():1610246. PubMed ID: 36017197
[TBL] [Abstract] [Full Text] [Related]
16. The state of PSA counseling in male-to-female transgender patients in the U.S.
Marthi S; O'Rourke TK; Tucci C; Pareek G; Hyams E
Prostate; 2022 Oct; 82(14):1315-1321. PubMed ID: 35748021
[TBL] [Abstract] [Full Text] [Related]
17. AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment.
Prisciandaro J; Zoberi JE; Cohen G; Kim Y; Johnson P; Paulson E; Song W; Hwang KP; Erickson B; Beriwal S; Kirisits C; Mourtada F
Med Phys; 2022 Aug; 49(8):e983-e1023. PubMed ID: 35662032
[TBL] [Abstract] [Full Text] [Related]
18. Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.
Stasinou D; Patatoukas G; Kollaros N; Diamantopoulos S; Kypraiou E; Kougioumtzopoulou A; Kouloulias V; Efstathopoulos E; Platoni K
Med Phys; 2022 Jul; 49(7):4322-4334. PubMed ID: 35560362
[TBL] [Abstract] [Full Text] [Related]
19. GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome.
Liu D; Che B; Chen P; He J; Mu Y; Chen K; Zhang W; Xu S; Tang K
J Clin Lab Anal; 2022 Apr; 36(4):e24352. PubMed ID: 35293017
[TBL] [Abstract] [Full Text] [Related]
20. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
[TBL] [Abstract] [Full Text] [Related]
[Next]
